TNF-based therapy (Tragen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTNF-based therapy (Tragen)
Drug Alias NameAd-CD154-TNF
ClassificationCell and gene therapy > Cell therapyCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionTumor necrosis factor agonists
TargetsTumor necrosis factor
Therapy Area/IndicationsSolid tumoursLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTragen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTragen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursLeukemia

Other Information

ATC CodeN/A
Related LinksN/A